NR4A1 and breast cancer: Of patients that harbored a gBRCA1pv (n = 95), 7 (7.4%) had hormone receptor-positive BC and 88 (92.6%) had TNBC, while in patients with a gBRCA2pv (n = 45), 15 (33.3%) had hormone receptor-positive BC and 30 (66.7%) had TNBC.